Pancreatic cancer and supportive care - Pancreatic exocrine insufficiency negatively impacts on quality of life

Supportive Care in Cancer

Volumn 21, Issue 7, 2013, Pages 1835-1841

  Gooden, H M ^a   White, K J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Nutrition; Pancreatic exocrine insufficiency; Pancreatic neoplasms; Quality of life; Weight loss

Indexed keywords

ANTINEOPLASTIC AGENT; PANCRELIPASE;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER STAGING; CAREGIVER BURDEN; CLINICAL ARTICLE; CONTENT ANALYSIS; DIET SUPPLEMENTATION; DISTRESS SYNDROME; FEMALE; HEALTH CARE ACCESS; HUMAN; MALABSORPTION; MALE; NUTRITION EDUCATION; NUTRITIONAL ASSESSMENT; PANCREAS CANCER; PANCREAS EXOCRINE INSUFFICIENCY; PANCREATICODUODENECTOMY; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITATIVE RESEARCH; QUALITY OF LIFE; TELECONSULTATION; THEMATIC ANALYSIS;

ADULT; AGED; CAREGIVERS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PANCREATIC NEOPLASMS; QUALITY OF LIFE; SOCIAL SUPPORT;

EID: 84878676650     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1729-3     Document Type: Article

References (39)

1. Speer AG et al (2012) Pancreatic cancer: surgical management and outcomes after 6 years of follow-up. Med J Aust 196(8):511-515
2. American Cancer Society (2012) Cancer facts and figures 2012. American Cancer Society, Atlanta
3. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries (2008) Cancer in Australia: an overview 2008. Australian Institute of Health and Welfare, Canberra
4. Nieto J, Grossbard ML, Kozuch P (2008) Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist 2008(13):562-576
5. Cancer Council NSW (2009) Available from: http://www.cancercouncil.com. au/2009/about-us/about-cancer-council-nsw/general-information/did-you-know/?pp= 41927. Accessed 19 Sep 2012
6. Robotin MC et al (2010) Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes Control 21(5):729-736
7. Turoff M (1975) The policy Delphi. In: Linstone H, Turoff M (eds) The Delphi method: techniques and applications. Addison-Wesley, Boston, pp 84-101
8. Saunders C et al (2009) As the bell tolls: a foundation study on pancreatic cancer consumer's research priorities. BMC Res Notes 2:179-188
9. Biankin AV et al (2009) Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. Gastroenterology 137(2):558-568.e11
10. Chang DK et al (2008) Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J Gastroenterol Hepatol 23(7 Pt 1):1036-1045
11. Colvin EK et al (2008) Individualizing therapy for pancreatic cancer. J Gastroenterol Hepatol 23(12):1779-1782
12. Lowery MA, O'Reilly EM (2012) Genomics and pharmacogenomics of pancreatic adenocarcinoma. Pharmacogenomics J 12(1):1-9
13. Petrin K et al (2009) Adjusting to pancreatic cancer: perspectives from first-degree relatives. Palliat Support Care 7(3):281-288
14. Sharma C et al (2011) Adjuvant therapy of pancreatic cancer. J Pancreas 12(4):343-346
15. Romanus D et al (2012) Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). J Pain Symptom Manage 43(2):205-217
16. Jamieson NB et al (2011) Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clin Cancer Res 17(10):3316-3331
17. Collisson EA et al (2011) Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 17(4):500-503
18. Renouf D, Moore M (2010) Evolution of systemic therapy for advanced pancreatic cancer. Expert Rev Anticancer Ther 10(4):529-540
19. Harinck F et al (2010) Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer. Dig Dis 28(4-5):670-678
20. Stapley S et al (2012) The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records. Br J Cancer 106(12):1940-1944
21. Bachet JB, Marechal R, van Laethem JL (2011) Treatment of pancreatic cancer: what can we really predict today? Cancer 3(1):675-699
22. Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7:163-172
23. Vincent A et al (2011) Pancreatic cancer. Lancet 378:607-620
24. Zabora J, Brintzenhofeszoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10:19-28
25. Clark KL et al (2010) Psychological distress in patients with pancreatic cancer-an understudied group. Psychooncology 19(12):1313-1320
26. Jia L et al (2010) Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion 82(1):4-9
27. Pappas S, Krzywda E, McDowell N (2010) Nutrition and pancreaticoduodenectomy. Nutr Clin Pract 25(3):234-243
28. Damerla V et al (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393-396
29. Davidson W et al (2004) Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. Clin Nutr 23(2):239-247
30. DiMagno EP, Malagelada JR, Go VL (1979) The relationships between pancreatic ductal obstruction and pancreatic secretion in man. Mayo Clin Proc 54(3):157-162
31. Dominguez-Munoz JE (2011) Pancreatic exocrine insufficiency: diagnosis and treatment. J Gastroenterol Hepatol 26(Suppl 2):12-16
32. Bachmann J et al (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12(7):1193-1201
33. Birkmeyer JD et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346(15):1128-1137
34. Finks JF, Osborne NH, Birkmeyer JD (2011) Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med 364(22):2128-2137
35. Fennell ML et al (2010) The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. JNCI Monogr 2010(40):72-80
36. de Wilde RF et al (2012) Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg 99(3):404-410
37. Gooiker GA et al (2011) Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg 98(4):485-494
38. NCCN (2013) NCCN Clinical Practice Guidelines in Oncology - pancreatic adenocarcinoma, version 2.2012. Available from: http://www.nccn.org/ professionals/physician-gls/pdf/pancreatic.pdf. Accessed 19 Sep 2012
39. Toouli J et al (2010) Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med J Aust 193(8):461-467